Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO 2019 Congress

Biosimilars use in oncology: Clarifying concepts

Impact of biosimilars on the sustainability of healthcare systems

Date

27 Sep 2019

Session

Biosimilars use in oncology: Clarifying concepts

Topics

Cancer Care Equity Principles and Health Economics;  Bioethical Principles and GCP;  Patient Education and Advocacy

Tumour Site

Presenters

Murray Aitken

Authors

M. Aitken

Author affiliations

  • Quintilesims Institute, IMS Health, NJ 07054 - Parsippany/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.